Company: CXAI
Filing Date: 2025-08-11
Form Type: S-3
Source: 0001829126-25-006018
Chunk: 17

Company: CXApp Inc.
Filing Date: 2025-08-11
Form: S-3
Chunk 17
---
 transferable; |
| ● | a discussion of any material U.S. federal income tax considerations applicable to the exercise of the warrants;                                       |
| ● | the date on which the right to exercise the warrants will commence, and the date on which the right will expire;                                      |
| ● | the maximum or minimum number of warrants that may be exercised at any time;                                                                          |
| ● | information with respect to book-entry procedures, if any; and                                                                                        |
| ● | any other terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.                   |

Exercise of Warrants

Each warrant will entitle the holder of warrants to purchase for cash the amount of common stock or preferred stock at the exercise price stated or determinable in the prospectus supplement for the warrants. Warrants may be exercised at any time up to the close of business on the expiration date shown in the applicable prospectus supplement, unless otherwise specified in such prospectus supplement. After the close of business on the expiration date, if applicable, unexercised warrants will become void. Warrants may be exercised as described in the applicable prospectus supplement. When the warrant holder makes the payment and properly completes and signs the warrant certificate at the corporate trust office of the warrant agent or any other office indicated in the prospectus supplement, we will, as soon as possible, forward the common stock or preferred stock that the warrant holder has purchased. If the warrant holder exercises the warrant for less than all of the warrants represented by the warrant certificate, we will issue a new warrant certificate for the remaining warrants.

Public Warrants

As of August 8, 2025,
there were 10,751,862 public warrants outstanding. Each whole warrant entitles the holder thereof to purchase one share of our common
stock at a price of $11.50 per share, subject to adjustments as set forth in the public warrants.

The Public Warrants are exercisable and will expire on March 15, 2028 or earlier upon redemption or liquidation. Public Warrants may only be exercised for a whole number of shares. No fractional warrants were issued upon separation of the units and only whole warrants trade.

If the common stock is at the time of any exercise of a public warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act (or any successor statute), the Company may, at its option, (i) require holders of